Viewing data from:

DOCOSANOL

ANDA

DOCOSANOL | A208754 | P AND L DEVELOPMENT LLC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$6.82

per gm

Lowest NADAC/Unit

$6.82

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
61269098135DOCOSANOL 10% CREAM	$6.82	GM	Generic	—	2026-06-17
46122068107GNP DOCOSANOL 10% CREAM	$6.82	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs

5 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVDOCOSANOL

DMF 294102015

BIOPHORE INDIA PHARMACEUTICALS PVT LTDDOCOSANOL

DMF 330642018

TARO PHARMACEUTICAL INDUSTRIES LTDDOCOSANOL

DMF 331652019

MAITHRI DRUGS PRIVATE LTDDOCOSANOL

DMF 332292018

APITORIA PHARMA PRIVATE LTDDOCOSANOL

DMF 351642020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 20, 2018	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 10%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Nov 19, 2018

No patent or exclusivity listings for this strength.